ArticleTherapeutic advances in gastroenterology2021

Long-term safety and efficacy study of a medical device containing xyloglucan, pea protein reticulated with tannins and xylo-oligosaccharides, in patients with diarrhoea-predominant irritable bowel syndrome.

Constanza Ciriza de Los Rios et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.